Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats
If you need more individualized support, reach out to set up a free discovery call with Kristyn Hall
It is most critical for patients over 50, perimenopausal or postmenopausal women, and anyone with prior sarcopenia or low baseline muscle mass
A thorough medical evaluation is needed to determine if this treatment is a safe and effective choice for you
Regular check-ins give your provider the chance to adjust dosing, review symptoms, and make sure your plan continues to support both results and drug safety
The gold standard in medicine is a head-to-head trial: give one group retatrutide, another group tirzepatide, and see who loses more weight under identical conditions